Fred Grier’s Post

Great quarter to be in SD Biotech: "In San Diego, startup funding for the second quarter surpassed $1 billion for the fifth consecutive year, driven by dozens of tech and life science venture capital fundings. San Diego saw roughly 42 deals in Q2 including four startups raising $100+ million, known as mega-deals." Top five largest bio deals: Endeavor BioMedicines: a Solana Beach-based biotech raised $132 million Alterome Therapeutics, Inc: an early-stage biotech raised $132 million. Enlaza Therapeutics: a La Jolla-based company raised $100 million. Bright Peak Therapeutics: a Del Mar-based biotech raised $90 million. Aardvark Therapeutics: a UTC-based biotech raised $85 million.

Our next business event covers all things venture capital. If you're a physics-powered start-up or small business looking for investment, come along to this online briefing and learn about attracting investment for your business!

Dive into the world of AgriTech and explore the evolution of funding in the industry, from self-funding to venture capital, with experts from Hamilton Locke and Findex, on Nov 30th. Register below!

Join us as we delve into "The Changing Landscape of Venture Capital" with Enis Hulli, Hussein Kanji, Itxaso del Palacio, PhD and Magnus Karnehm coming together for an insightful panel. It's going to be enlightening! #techeusummit24

Looking forward to this webinar. Jump on and register to learn about capital raising and IP.

Capitalizing on Innovation: Dive into the world of venture capital resolutions in 2024, reshaping strategies for a dynamic future! 💡🚀 Explore transformative milestones, industry applications, and emerging trends shaping the investment landscape. In this feature, we reveal solutions that promise to revolutionize your venture capital approach. Read the full article on our site - https://lnkd.in/g_7W9y8Y #InnovationCapital #VentureCapital #2024Resolutions #TechRevolution #InvestmentStrategies

AQUATY’s new €2.3M pre-seed funding breaks barriers to venture capital. You’re not alone if you’ve faced obstacles in venture capital. AQUATY’s technology platform is here to change that. 1. Ease of Transactions: As simple as buying stocks. 2. Transparency: AI-driven insights for smart decisions. 3. Accessibility: Invest from €1,000, like an index-ETF for early-stage investments. Imagine streamlined VC Investments and wider market access. How do you see AQUATY transforming your investment approach? Robert Jeggle (geb. Menzel), Andy Lenz, Alexander Grimm, Sebastian Otutuama, Tristan Hammer,   https://lnkd.in/draStFAa #VentureCapital #TechInnovation #InvestSmart #MondayFunding

New Ventures, New Strategies: VC Resolutions for 2024 🌐 Embark on a journey into the resolutions shaping the world of venture capitalism in 2024! Swipe through as we explore the rise of specialist funds, the diversification dilemma, and strategies for navigating risks in specialization. Find out how venture capitalists are striking the right balance between specialization and diversification to thrive in the dynamic investment landscape! 💼💡 Learn more about AI applications with us https://lnkd.in/gssiheet #VCResolutions #NewVentures2024 #InvestmentStrategies